These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33486603)

  • 21. Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates.
    Patra A; Thakkar PS; Makhoul M; Bada HS
    Front Pediatr; 2021; 9():648584. PubMed ID: 33718311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the clinical significance of echocardiograms in determining treatment of patent ductus arteriosus in neonates.
    Youssef D; Flores MN; Ebrahim E; Eshak K; Westerink J; Chaudhuri D; Balakrishnan N; Mukerji A; Mondal T
    J Neonatal Perinatal Med; 2020; 13(3):345-350. PubMed ID: 32925117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early prediction of a significant patent ductus arteriosus in infants <32 weeks gestational age.
    Katheria V; Poeltler DM; Brown MK; Hassen KO; Patel D; Rich W; Finer NN; Katheria AC
    J Neonatal Perinatal Med; 2018; 11(3):265-271. PubMed ID: 29843271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral perfusion and assessing hemodynamic significance for patent ductus arteriosus using near infrared red spectroscopy in very low birth weight infants.
    Poon WB; Tagamolila V
    J Matern Fetal Neonatal Med; 2021 May; 34(10):1645-1650. PubMed ID: 31303077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Tool for Closure of Ductus Arteriosus with Pharmacologic or Surgical Treatment in Preterm Infants.
    Liu T; Chen Z; Ma X; Shi L
    Pediatr Cardiol; 2022 Feb; 43(2):373-381. PubMed ID: 34510236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
    Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
    BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-infrared spectroscopy for detection of a significant patent ductus arteriosus.
    Chock VY; Rose LA; Mante JV; Punn R
    Pediatr Res; 2016 Nov; 80(5):675-680. PubMed ID: 27603562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.
    Su BH; Lin HY; Chiu HY; Tsai ML; Chen YT; Lu IC
    Pediatr Neonatol; 2020 Apr; 61(2):133-141. PubMed ID: 31740267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective factors against preterm infants to develop significant patent ductus arteriosus.
    Huang HW; Lin C; Hsu KH; Hsu SY; Mok TY; Wu IH; Lai MY; Lien R
    Pediatr Neonatol; 2021 Jul; 62(4):379-386. PubMed ID: 33931344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early predictive echocardiographic features of hemodynamically significant patent ductus arteriosus in preterm VLBW infants.
    Polat TB; Celik IH; Erdeve O
    Pediatr Int; 2016 Jul; 58(7):589-94. PubMed ID: 26754187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
    Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
    J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent Ductus Arteriosus of the Preterm Infant.
    Hamrick SEG; Sallmon H; Rose AT; Porras D; Shelton EL; Reese J; Hansmann G
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: Red cell distribution width-to-platelet ratio.
    Özer Bekmez B; Tayman C; Büyüktiryaki M; Çetinkaya AK; Çakır U; Derme T
    J Clin Lab Anal; 2018 Nov; 32(9):e22616. PubMed ID: 29978492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.
    Slaughter JL; Cua CL; Notestine JL; Rivera BK; Marzec L; Hade EM; Maitre NL; Klebanoff MA; Ilgenfritz M; Le VT; Lewandowski DJ; Backes CH
    BMC Pediatr; 2019 Sep; 19(1):333. PubMed ID: 31519154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral oxygenation during different treatment strategies for a patent ductus arteriosus.
    Chock VY; Ramamoorthy C; Van Meurs KP
    Neonatology; 2011; 100(3):233-40. PubMed ID: 21701212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants.
    Dani C; Poggi C; Cianchi I; Corsini I; Vangi V; Pratesi S
    Eur J Pediatr; 2018 Apr; 177(4):533-539. PubMed ID: 29372379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Conservative Approach for Persistent Patent Ductus Arteriosus in Preterm Infants: Neurodevelopmental Outcomes at 5 Years of Age.
    Kaga M; Sanjo M; Sato T; Miura Y; Ono T
    Tohoku J Exp Med; 2019 Nov; 249(3):155-161. PubMed ID: 31708567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidants and Biomarkers of Oxidative Stress in Preterm Infants with Symptomatic Patent Ductus Arteriosus.
    Inayat M; Bany-Mohammed F; Valencia A; Tay C; Jacinto J; Aranda JV; Beharry KD
    Am J Perinatol; 2015 Jul; 32(9):895-904. PubMed ID: 25715313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.